Longitudinal, multi-source, curated datasets, offering rapid access to deep clinical data, insights and outcomes in Parkinson’s Disease (PD).
Research-Grade RWD in Parkinson’s Disease
Americans are living with Parkinson’s Disease, with experts arguing the number could be greater due to undiagnosed or misdiagnosed patients. There is currently no known cure and no interventions that meaningfully reduce the progression of the disease. While some medications can help control or lessen symptoms, these medications are most effective in the early stages.
Deep Clinical Data
Parkinson patients with deep clinical data longitudinally followed by neurologists with mean follow-up of 8 years (98% with linked EMR & claims).
*Counts complete through Q4 2023
Total Parkinson’s Disease patients in OM1 Real-World Data Cloud to use for advanced analytics and research
A Closer Look at the PD Network
730,000 Total Parkinson’s Disease patients in the OM1 Real-World Data Cloud
Award-Winning Research Team
Our team of award-winning researchers have authored hundreds of publications, including scientific posters, articles in peer-reviewed journals, white papers, and books.